BIO-key International Inc. (BKYI) carries a Roarable Rating of D- (Sell) with 35/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-03, BIO-key International Inc. (NASDAQ: BKYI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $2.45 (-9.26% 1D, market cap $5.5M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 7/20. Across 715 tracked Technology issuers, BKYI ranks #526 in composite RQD confidence.
Within the Technology sector (Computer Software: Prepackaged Software), BKYI carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 76.9%, and ROIC of -35.0%. By comparison, ORKT (Orangekloud Technology Inc. (Class A)) holds a E grade (30/100 RQD, P/E N/A, ROIC -35.0%, cap $5.8M) and LHSW (Lianhe Sowell International Group Ltd (Class A)) posts a E grade (31/100 RQD, P/E N/A, ROIC —, cap $5.9M). Among the 5-stock peer group, BKYI leads on earnings multiple (N/A) while BKYI leads on capital efficiency (-35.0% ROIC).
Per BKYI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001019034), BIO-key International Inc. generated $5.9M in revenue (-14.3% YoY), $7.2M in net income, and -$4.7M in free cash flow against $8.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
FRED Regime × Technicals: 7% of 52W Range • RSI-14 at 50.8 (NEUTRAL RANGE)
Capital intensity & 0% operating margin leave 16 pts on the table
While BKYI currently carries a cautious 35/100 (D-) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Technology with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.57) and Max Pain ($2.57) forces dealer call-delta covering toward $14.49.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.16% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
BIO-key International Inc. (BKYI) dropped -9.26% to $2.45, trading at 7% of its 52-week range ($1.55 – $13.8). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
Yahoo Finance report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
Moomoo report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
Investorideas.com report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
GuruFocus report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance Singapore report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
Quiver Quantitative report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
kalkine.ca report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
Timothy Sykes report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
Gainers PicoCELA (NASDAQ:PCLA) stock moved upwards by 34.6% to $7.9 during Thursday's pre-market session. The market value of their outstanding shares is at $56.4 million. Cohu (NASDAQ:COHU) stock moved upwards by
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -14.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BKYI today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BKYI. Explore sector supply chains on /butterfly.
Across 715 tracked Technology securities in the Roarable RQD universe, BIO-key International Inc. (BKYI) ranks #526 by composite RQD confidence (35/100, grade D-) and #669 by equity capitalization ($5.5M). Within this direct 5-issuer industry benchmark cohort, BKYI leads on earnings valuation at N/A trailing P/E, while BKYI leads on capital efficiency and profitability with -35.0% ROIC and 76.9% gross margin. BKYI currently leads its immediate peer cohort in composite quantitative strength at 35/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| BKYI
ACTIVE
BIO-key International Inc. | D- | 35/100 | — | 76.9% | -35.0% | -9.26% | $5.5M | Benchmark Subject |
| ORKT Orangekloud Technology Inc. (Class A) | E | 30/100 | — | 44.2% | -35.0% | -5.74% | $5.8M | /orkt-vs-bkyi → |
| LHSW Lianhe Sowell International Group Ltd (Class A) | E | 31/100 | — | 21.4% | — | +0.69% | $5.9M | /lhsw-vs-bkyi → |
| GYGY Game Your Game Inc. | E | 27/100 | — | 8.6% | -35.0% | -7.12% | $6.0M | /gygy-vs-bkyi → |
| IFBD Infobird Co. Ltd | E | 33/100 | — | 29.5% | -35.0% | +37.83% | $6.1M | /ifbd-vs-bkyi → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), BIO-key International Inc. (BKYI) reported GAAP revenue of $5.9M (-14.3% vs. FY2024 revenue of $6.9M , and -76.0% cumulative change since FY2023) , GAAP net income of $7.2M, operating cash flow of -$4.7M, and free cash flow of -$4.7M (-59.9% YoY). On the balance sheet, BKYI closed FY2025 with $8.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $5.9M | $7.2M | -$4.7M | -$4.7M | $8.3M | — |
| FY2024 (FY) | 2024-12-31 | $6.9M | $4.3M | -$2.9M | -$2.9M | $8.6M | $44.8K |
| FY2023 (FY) | 2023-12-31 | $24.7M | $8.5M | -$3.8M | -$3.8M | — | — |
As of 2026-11-03, BIO-key International Inc. (NASDAQ: BKYI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $2.45 (-9.26% 1D, market cap $5.5M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 7/20. Across 715 tracked Technology issuers, BKYI ranks #526 in composite RQD confidence.
Within the Technology sector (Computer Software: Prepackaged Software), BKYI carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 76.9%, and ROIC of -35.0%. By comparison, ORKT (Orangekloud Technology Inc. (Class A)) holds a E grade (30/100 RQD, P/E N/A, ROIC -35.0%, cap $5.8M) and LHSW (Lianhe Sowell International Group Ltd (Class A)) posts a E grade (31/100 RQD, P/E N/A, ROIC —, cap $5.9M). Among the 5-stock peer group, BKYI leads on earnings multiple (N/A) while BKYI leads on capital efficiency (-35.0% ROIC).
Per BKYI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001019034), BIO-key International Inc. generated $5.9M in revenue (-14.3% YoY), $7.2M in net income, and -$4.7M in free cash flow against $8.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
BKYI last traded at $2.45 (-9.26% on volume of 159,111 shares), positioning the stock -4.67% below its 50-day simple moving average ($2.57) and -45.92% below its 200-day simple moving average ($4.53). Across its 52-week range of $1.55 to $13.80, BKYI sits at the 7.3% percentile with a 14-day RSI of 50.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.14 to $2.76).
BIO-key International Inc. (BKYI) earns a live Roarable RQD composite score of 35/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $2.45 (-9.26% 1D, market capitalization $5.5M).
. Is a NASDAQ-listed issuer in the Technology sector, operating in Computer Software: Prepackaged Software. The profile reports a market capitalization of $0.0B. Customer base and revenue mechanics are — Gross margin is 76.9% per the market data, indicating high gross profitability on sold product, though operating margin is -60%.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), BIO-key International Inc. (BKYI) reported $5.9M in annual revenue (up from $6.9M in FY2024, -14.3% YoY) and $7.2M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($24.7M revenue, $8.5M net income) through FY2025, BKYI scaled operating cash flow to -$4.7M and free cash flow to -$4.7M, backed by $8.3M in total assets against $0 in total debt.
Upstream and downstream dependencies are — Sector correlation data beyond the stated beta of 1.0 is — Investors should watch whether new government contract wins translate into revenue lines visible in future filings, since the FY 2025 revenue decline indicates contract momentum has not yet shown up in reported results.
Real-time company headlines, analyst actions, and sector developments for BIO-key International Inc. (BKYI) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
Moomoo report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
Investorideas.com report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
GuruFocus report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance Singapore report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
Quiver Quantitative report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
kalkine.ca report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
Timothy Sykes report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.
A reported new Middle East government security agency customer and a 76.9% gross margin point to a possible revenue expansion path.. When you look under the hood at BKYI, Fundamental Cash Engine is 4/20 with 76.9% gross margins and -35.0% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (6/20) has been quietly accumulating below $13.80. My 12M target is $3.43.
@MidwestValue Agree on the RQD 35/100 quality, though with 1.0 beta I'm scaling in with half-size at $2.70 and keeping dry powder in case we test $2.51.
Careful chasing BKYI at $2.70. Operating income and free cash flow are negative in every reported period, with an ROIC of -35% and an RQD score of 38.. Gross margin is 76.9%, but operating margin is -60.0%, which shows SG&A and reinvestment are eating into bottom-line EPS. Target $2.24 on multiple compression.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Gideon Ashmere, Ellis Vennor, Tessa Rookmere, Soren Halewick, Iona Brackenford, Nadia Vellacrest, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your first name and email address below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).
Your $100,000 Virtual Cash Trading Account is active! Add your mobile number below if you want our #1 Weekly Quant Top Pick plus urgent breaking market alerts & SEC Form 4 CEO cluster-buy flashes sent straight to your phone: